Elisabetta Zanatta

Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase

F. Cacciapaglia, C. Campochiaro, G. de Luca, 2023, Journal of Translational Autoimmunity.

Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database

F. Mendoza, J. D. de Vries-Bouwstra, M. Cerinic, 2020, Arthritis Research & Therapy.

Evaluation of right ventricular function performed by 3D-echocardiography in scleroderma patients.

L. Badano, L. Punzi, F. Cozzi, 2015, Reumatismo.